Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.50 USD
−295.51 M USD
1.23 B USD
59.47 M
About ARGENX SE
Sector
CEO
Tim van Hauwermeiren
Headquarters
Amsterdam
Website
Founded
2008
FIGI
BBG00GHB88X9
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ARGX is featured.